Works matching IS 22113428 AND DT 2022 AND VI 45 AND IP 4


Results: 12
    1
    2
    3
    4

    Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models.

    Published in:
    Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 639, doi. 10.1007/s13402-022-00689-2
    By:
    • Li, Shulin;
    • Hoefnagel, Sanne J. M.;
    • Read, Matthew;
    • Meijer, Sybren;
    • van Berge Henegouwen, Mark I.;
    • Gisbertz, Suzanne S.;
    • Bonora, Elena;
    • Liu, David S. H.;
    • Phillips, Wayne A.;
    • Calpe, Silvia;
    • Correia, Ana C. P.;
    • Sancho-Serra, Maria D. C.;
    • Mattioli, Sandro;
    • Krishnadath, Kausilia K.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12